The N-myc Oncogene: Maximizing its Targets, Regulation, and Therapeutic Potential

被引:114
作者
Beltran, Himisha [1 ]
机构
[1] Weill Cornell Med Coll, New York, NY 10005 USA
关键词
IN-SITU HYBRIDIZATION; DEACETYLASE INHIBITOR BL1521; SMALL-MOLECULE INHIBITORS; SMALL-CELL-CARCINOMA; GENE AMPLIFICATION; C-MYC; DIFFERENTIAL EXPRESSION; ORNITHINE-DECARBOXYLASE; MALIGNANT PROGRESSION; EMBRYONIC LETHALITY;
D O I
10.1158/1541-7786.MCR-13-0536
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
N-myc (MYCN), a member of the Myc family of basic-helix-loop-helix-zipper (bHLHZ) transcription factors, is a central regulator of many vital cellular processes. As such, N-myc is well recognized for its classic oncogenic activity and association with human neuroblastoma. Amplification and overexpression of N-myc has been described in other tumor types, particularly those of neural origin and neuroendocrine tumors. This review outlines N-myc's contribution to normal development and oncogenic progression. In addition, it highlights relevant transcriptional targets and mechanisms of regulation. Finally, the clinical implications of N-Myc as a biomarker and potential as a target using novel therapeutic approaches are discussed. (C) 2014 AACR.
引用
收藏
页码:815 / 822
页数:8
相关论文
共 95 条
[1]  
Alaminos M, 2003, CANCER RES, V63, P4538
[2]  
Aldosari N, 2002, ARCH PATHOL LAB MED, V126, P540
[3]   Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets [J].
Beltran, Himisha ;
Rickman, David S. ;
Park, Kyung ;
Chae, Sung Suk ;
Sboner, Andrea ;
MacDonald, Theresa Y. ;
Wang, Yuwei ;
Sheikh, Karen L. ;
Terry, Stephane ;
Tagawa, Scott T. ;
Dhir, Rajiv ;
Nelson, Joel B. ;
de la Taille, Alexandre ;
Allory, Yves ;
Gerstein, Mark B. ;
Perner, Sven ;
Pienta, Kenneth J. ;
Chinnaiyan, Arul M. ;
Wang, Yuzhuo ;
Collins, Colin C. ;
Gleave, Martin E. ;
Demichelis, Francesca ;
Nanus, David M. ;
Rubin, Mark A. .
CANCER DISCOVERY, 2011, 1 (06) :487-495
[4]   Loss of a FYN-regulated differentiation and growth arrest pathway in advanced stage neuroblastoma [J].
Berwanger, B ;
Hartmann, O ;
Bergmann, E ;
Bernard, S ;
Nielsen, D ;
Krause, M ;
Kartal, A ;
Flynn, D ;
Wiedemeyer, R ;
Schwab, M ;
Schäfer, H ;
Christiansen, H ;
Eilers, M .
CANCER CELL, 2002, 2 (05) :377-386
[5]   Histone H3.3 Mutations Drive Pediatric Glioblastoma through Upregulation of MYCN [J].
Bjerke, Lynn ;
Mackay, Alan ;
Nandhabalan, Meera ;
Burford, Anna ;
Jury, Alexa ;
Popov, Sergey ;
Bax, Dorine A. ;
Carvalho, Diana ;
Taylor, Kathryn R. ;
Vinci, Maria ;
Bajrami, Ilirjana ;
McGonnell, Imelda M. ;
Lord, Christopher J. ;
Reis, Rui M. ;
Hargrave, Darren ;
Ashworth, Alan ;
Workman, Paul ;
Jones, Chris .
CANCER DISCOVERY, 2013, 3 (05) :512-519
[6]   MAX - A HELIX-LOOP-HELIX ZIPPER PROTEIN THAT FORMS A SEQUENCE-SPECIFIC DNA-BINDING COMPLEX WITH MYC [J].
BLACKWOOD, EM ;
EISENMAN, RN .
SCIENCE, 1991, 251 (4998) :1211-1217
[7]   N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis [J].
Boon, K ;
Caron, HN ;
van Asperen, R ;
Valentijn, L ;
Hermus, MC ;
van Sluis, P ;
Roobeek, I ;
Weis, I ;
Voûte, PA ;
Schwab, M ;
Versteeg, R .
EMBO JOURNAL, 2001, 20 (06) :1383-1393
[8]   Prognostic significance of MYCN oncogene expression in childhood neuroblastoma [J].
Bordow, SB ;
Norris, MD ;
Haber, PS ;
Marshall, GM ;
Haber, M .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (10) :3286-3294
[9]   Myc represses transcription through recruitment of DNA methyltransferase corepressor [J].
Brenner, C ;
Deplus, R ;
Didelot, C ;
Loriot, A ;
Viré, E ;
De Smet, C ;
Gutierrez, A ;
Danovi, D ;
Bernard, D ;
Boon, T ;
Pelicci, PG ;
Amati, B ;
Kouzarides, T ;
de Launoit, Y ;
Di Croce, L ;
Fuks, F .
EMBO JOURNAL, 2005, 24 (02) :336-346
[10]   Small Molecule Inhibitors of Aurora-A Induce Proteasomal Degradation of N-Myc in Childhood Neuroblastoma [J].
Brockmann, Markus ;
Poon, Evon ;
Berry, Teeara ;
Carstensen, Anne ;
Deubzer, Hedwig E. ;
Rycak, Lukas ;
Jamin, Yann ;
Thway, Khin ;
Robinson, Simon P. ;
Roels, Frederik ;
Witt, Olaf ;
Fischer, Matthias ;
Chesler, Louis ;
Eilers, Martin .
CANCER CELL, 2013, 24 (01) :75-89